Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole in Restless Legs Syndrome
NCT00133198Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2004
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pramipexole in restless legs syndrome (RLS), sponsored by Boehringer Ingelheim. Started Apr 2004; status: completed.
02
Drugs
pramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00133198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133198.